Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Alzheimer's Disease

  Free Subscription


29.07.2019

2 Alzheimer Dis Assoc Disord
1 Alzheimers Dement
1 Ann Pharmacother
1 J Neurosci
2 N Engl J Med
1 Neurosci Lett
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. SALCEDO-TACUMA D, Melgarejo JD, Mahecha MF, Ortega-Rojas J, et al
    Differential Methylation Levels in CpGs of the BIN1 Gene in Individuals With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2019 Jul 19. doi: 10.1097/WAD.0000000000000329.
    PubMed     Text format     Abstract available

  2. CIPOLLINI V, Sette G, Bossu P, Ciaramella A, et al
    Neurovascular Dysfunction in Alzheimer Disease: Assessment of Cerebral Vasoreactivity by Ultrasound Techniques and Evaluation of Circulating Progenitor Cells and Inflammatory Markers.
    Alzheimer Dis Assoc Disord. 2019 Jul 19. doi: 10.1097/WAD.0000000000000331.
    PubMed     Text format     Abstract available


    Alzheimers Dement

  3. FILSHTEIN TJ, Brenowitz WD, Mayeda ER, Hohman TJ, et al
    Reserve and Alzheimer's disease genetic risk: Effects on hospitalization and mortality.
    Alzheimers Dement. 2019;15:907-916.
    PubMed     Text format     Abstract available


    Ann Pharmacother

  4. SEPASSI A, Watanabe JH
    Emergency Department Visits for Psychotropic-Related Adverse Drug Events in Older Adults With Alzheimer Disease, 2013-2014.
    Ann Pharmacother. 2019 Jul 25:1060028019866927. doi: 10.1177/1060028019866927.
    PubMed     Text format     Abstract available


    J Neurosci

  5. HUANG YA, Zhou B, Nabet AM, Wernig M, et al
    Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    J Neurosci. 2019 Jul 22. pii: JNEUROSCI.2994-18.2019.
    PubMed     Text format     Abstract available


    N Engl J Med

  6. KENNEDY ME, Egan MF
    Verubecestat for Prodromal Alzheimer's Disease. Reply.
    N Engl J Med. 2019;381:389.
    PubMed     Text format    

  7. LI S, Liu L, Selkoe D
    Verubecestat for Prodromal Alzheimer's Disease.
    N Engl J Med. 2019;381:388.
    PubMed     Text format    


    Neurosci Lett

  8. BALES KR, Paul SM
    Targeting apolipoprotein E for treating Alzheimer's disease.
    Neurosci Lett. 2019 Jul 20:134366. doi: 10.1016/j.neulet.2019.134366.
    PubMed     Text format     Abstract available


    PLoS One

  9. ROCHOY M, Bordet R, Gautier S, Chazard E, et al
    Factors associated with the onset of Alzheimer's disease: Data mining in the French nationwide discharge summary database between 2008 and 2014.
    PLoS One. 2019;14:e0220174.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: